Aster Capital Management’s AbbVie ABBV Stock Holding History

Aster Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$172K	Sell	685 -2,644	-79%	-$569K	0.04%	434
2026 Q1	$697K	Sell	3,329 -7	-0.2%	-$1.55K	0.23%	104
2025 Q4	$762K	Sell	3,336 -5,579	-63%	-$1.27M	0.33%	50
2025 Q3	$2.06M	Buy	+8,915	New	+$1.82M	1.04%	13
2024 Q4	–	Sell	-7,406	Closed	-$1.46M	–	1078
2024 Q3	$1.46M	Buy	+7,406	New	+$1.38M	0.32%	78

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aster Capital Management's ABBV Position: Q2 2026 in Review

Aster Capital Management reduced its AbbVie (ABBV) stake by 79% in Q2 2026, selling an estimated $569K and leaving 685 shares worth $172K. The position accounts for 0.04% of the portfolio, ranked #434.

Aster Capital Management first reported a position in ABBV in Q3 2024 and has held it in 5 quarters since. The position peaked at $2.06M in Q3 2025. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Aster Capital Management held 685 shares of AbbVie worth $172K as of Q2 2026.
Aster Capital Management sold 2,644 AbbVie shares in Q2 2026, an estimated $569K.
AbbVie made up 0.04% of Aster Capital Management's portfolio in Q2 2026, its #434 holding.
Aster Capital Management first reported a position in AbbVie in Q3 2024 and has held it in 5 quarters since.
Aster Capital Management's AbbVie position peaked at $2.06M in Q3 2025.
4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.